$1.880
+0.051 (+2.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ERNA Prediction & Forecast by Similar Chart Analysis
Alphio's ERNA stock price prediction model matches the current Ernexa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.90 (+0.93%). The 1-week path is $1.98 (+5.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ernexa Therapeutics Inc Stock?
Eterna Therapeutics Inc (ERNA) is not a good buy right now due to its poor financial performance and negative market trends. The stock has a current price of 1.88, which is a drastic drop of 93.52% year-to-date. Additionally, the RSI is at 36.6, indicating that the stock is nearing oversold territory, but this alone does not justify a buy given the lack of revenue and significant losses reported. The company has a forward P/E of 0, indicating no expected earnings growth, and a gross margin of 0% for the upcoming quarters, which raises concerns about its operational viability. The main risk is the ongoing net losses, with the most recent quarter showing a loss of 5.51 million, which could further erode investor confidence.
ERNA stock price ended at $1.88 on Friday, after rising +2.73%
Ernexa Therapeutics Inc (ERNA) last closed at $1.88, gaining +2.73%. These facts feed the 1-day and 1-week ERNA price prediction above.
Forecast Drivers
Ernexa Therapeutics Inc (ERNA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ERNA, ranked by similarity.
Seasonality analysis for ERNA
Historically the probability of a positive November return for ERNA is 0.00%. January offers the highest probability of a positive month at 57.38%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ERNA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.29 | $2.39 | $2.58 | +27.17% |
| Dec 2026 | $2.12 | $2.31 | $2.61 | +23.00% |
In 2026, Ernexa Therapeutics Inc (ERNA) is projected to range from $2.12 to $2.61.
Ernexa Therapeutics Inc 2026 monthly forecast
In Nov 2026, Ernexa Therapeutics Inc is projected to average $2.39, with a low of $2.29 and high of $2.58.
In Dec 2026, Ernexa Therapeutics Inc is projected to average $2.31, with a low of $2.12 and high of $2.61.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.